A guide and coaching sessions to help people with a high-grade brain tumor cope
Official title: NeuroPathways Intervention for Brain Tumor Patients
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study tests a support program for people with a high-grade brain tumor.
Read our full plain-language summary
What the trial team says
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
Key facts
- Registry number
- NCT05976490
- Stage of testing
- Not applicable
- Conditions studied
- Malignant Brain Tumor, Glioma, Coping Skills
Where it is running
This trial lists 1 site.
-
Massachusetts
- Massachusetts General Hospital Cancer Center (Boston)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.